Canary Capital Brings Injective to Nasdaq With New INJ Staked ETF

Canary Capital has launched an exchange-traded fund for Injective’s INJ token, allowing investors to gain exposure to the cryptocurrency and earn potential staking rewards. Digital asset investment management firm Canary Capital has launched an exchange-traded fund (ETF) based on Injective (INJ), providing investors exposure to the cryptocurrency through traditional brokerage accounts. In addition, the product offers potential returns from blockchain staking rewards . The firm’s CEO, Steven McClurg, said the launch expands Canary Capital’s digital asset investment offerings, which include the Canary XRP ETF and Canary HBAR ETF.

Source: Bitcoin.com News